Trial · NCT04349072
Adverse events142
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 142
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | COVID-19 | Infections and infestations | Mavacamten | 39 | 108 | |
| other | COVID-19 | Infections and infestations | Placebo | 2 | 55 | |
| other | Upper respiratory tract infection | Infections and infestations | Mavacamten | 15 | 108 | |
| other | Upper respiratory tract infection | Infections and infestations | Placebo | 0 | 55 | |
| other | Urinary tract infection | Infections and infestations | Mavacamten | 15 | 108 | |
| other | Urinary tract infection | Infections and infestations | Placebo | 1 | 55 | |
| other | Ejection fraction decreased | Investigations | Mavacamten | 12 | 108 | |
| other | Ejection fraction decreased | Investigations | Placebo | 0 | 55 | |
| other | SARS-CoV-2 test positive | Investigations | Mavacamten | 9 | 108 | |
| other | SARS-CoV-2 test positive | Investigations | Placebo | 1 | 55 | |
| other | Gout | Metabolism and nutrition disorders | Mavacamten | 6 | 108 | |
| other | Gout | Metabolism and nutrition disorders | Placebo | 0 | 55 | |
| other | Hyperlipidaemia | Metabolism and nutrition disorders | Mavacamten | 6 | 108 | |
| other | Hyperlipidaemia | Metabolism and nutrition disorders | Placebo | 0 | 55 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Mavacamten | 13 | 108 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Placebo | 0 | 55 | |
| other | Muscular weakness | Musculoskeletal and connective tissue disorders | Mavacamten | 6 | 108 | |
| other | Muscular weakness | Musculoskeletal and connective tissue disorders | Placebo | 1 | 55 | |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Mavacamten | 6 | 108 | |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Placebo | 1 | 55 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04349072/events?page=2